| |
|
ABSTRACT |
SLIDES |
|
| 8:00 |
Registration Royal Armories |
|
|
|
| 9:00 |
Welcome and Introduction |
|
|
|
| 9:10 |
Long Term Comparison of Current Treatment Modalities for Prostate Cancer |
|
 |
Dr Peter Grimm
Prostate Cancer Center of Seattle |
| 9:50 |
Paul Evans Memorial lecture: ‘Current status of HDR brachytherapy for prostate cancer in the UK’ |
|
|
Professor Peter Hoskin
Mount Vernon Cancer Centre, Middlesex |
| 10:30 |
Refreshments and exhibition |
|
|
|
| 11:00 |
Prostate and normal tissue constraints to optimize HDR brachytherapy |
|
|
Professor Alvaro Martinez
William Beaumont Hospital, Michigan |
|
11.40 |
How can we best use HDR brachytherapy to escalate dose in intermediate and high risk disease? |
|
|
Dr Gerard Morton
Odette Cancer Centre, Toronto |
| 12.30 |
Lunch |
|
|
|
| 13.30 |
Prize Abstracts: 5 each of ten minutes |
|
|
|
|
Dispelling the Myth: TURP Does not cause Post-BXT Incontinence or Prevent Adequate Implant. |
 |
|
Eliot Chadwick
St Lukes Cancer Centre, Royal Surrey County Hospital |
|
Multi-institutional outcomes following LDR brachytherapy in patients with higher risk cancer. |
|
|
Ruth Conroy
Christie Hospital, Manchester |
| WINNER |
The risk of second cancers occurring more than 5 years after I-125 monotherapy for early prostate cancer. |
|
|
Hima Musunuru
St James’s Institute of Oncology, Leeds |
|
Impact and recovery of health related quality of life after single fraction HDR brachytherapy and EBRT for prostate cancer. |
|
|
Jahangeer Malik
Christie Hospital, Manchester |
|
Functional MRI guided HDR prostate brachytherapy tumour boost: a feasibility study. |
|
|
Joshua Mason
St James’s Institute of Oncology, Leeds |
| 14.30 |
Quality Assurance Practice Guidelines for Transperineal Permanent Seed Brachytherapy of Prostate Cancer |
|
|
Dr Robert Laing and Mr Peter Bownes
St Lukes Cancer Centre, Guildford and St James’s Institute of Oncology, Leeds |
| 15.00 |
Refreshments and exhibition |
|
|
|
| 15.30 |
Optimising the Design of your Brachytherapy Service |
|
|
Mrs Cathy Taylor
Christie Hospital, Manchester |
| 16.00 |
Debate: Over the next decade permanent seeds will remain the optimal brachytherapy treatment for early prostate cancer |
|
|
Chair: Dr David Bottomley |
| |
For: |
|
|
Dr Peter Grimm |
| |
|
|
|
Professor Peter Hoskin |
| |
Against |
|
|
Professor Alvaro Martinez |
| |
|
|
|
Dr Gerard Morton |
| 17.15 |
Prize abstract presentation and Close |
|
|
|
| 19.30 |
Conference Dinner at the Royal Armories |
|
|
|
